Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193420 | SCV000246411 | benign | not specified | 2016-08-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000872096 | SCV001013861 | benign | KBG syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001682905 | SCV001904905 | benign | not provided | 2021-03-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000872096 | SCV002525190 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001682905 | SCV002563363 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | ANKRD11: BP4, BP7 |
Ambry Genetics | RCV002345686 | SCV002653803 | likely benign | Inborn genetic diseases | 2017-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000872096 | SCV005879799 | benign | KBG syndrome | 2024-11-12 | criteria provided, single submitter | clinical testing |